References
- Calda P. Ultrasonographic and biochemical markers in prenatal detection of Down's syndrome and neural tube defects. Funct Dev Morphol. 1992;2:135–7.
- Stejskal D. Screening for Down's syndrome in the 2nd trimester of pregnancy: initial results. Cesk Gynekol. 1993;58:5–10.
- Gregor V, Sipek A, Sipek A Jr, Horacek J, Langhammer P, Petrzilkova L, Prenatal diagnostics of chromosomal aberrations Czech Republic: 1994 – 2007. Ceska Gynekol. 2009;74:44–54.
- Calda P, Viskova H, Bezdickova D, Zima T. Prenatal diagnostics during the first trimester in the clinical praxis. Cas Lek Cesk. 2006;145:575–7.
- Congenital anomalies in births in year 2007. Prague: Institute of Health Information and Statistics (UZIS CR), 2009.
- Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol. 2005;29:252–7.
- Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ. 2008;337:a2547.
- Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31:618–24.
- Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol. 2006;108:612–16.
- Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol. 2006;108:1067–72.
- Fang YM, Benn P, Campbell W, Bolnick J, Prabulos AM, Egan JF. Down syndrome screening in the United States in 2001 and 2007: a survey of maternal–fetal medicine specialists. Am J Obstet Gynecol. 2009;201:97, e1–5.